Hospitalized patients who had impaired first-phase ejection fraction were nearly 5 times more likely to die from COVID-19 compared to patients with normal first-phase ejection fraction.
Early measurement of first-phase ejection fraction in hospitalized COVID-19 patients could help clinicians identify high-risk patients, tailor treatments and potentially help prevent deaths.
© American Heart Association